Keyphrases
Migraine
100%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
100%
Dilatation
100%
Mouse Model
100%
Carotid Artery
100%
VPAC2 Receptor
100%
VPAC1 Receptors
100%
PACAP-38
100%
Hind Paw
100%
Peptide Receptor
72%
Knock-in Mouse Model
36%
PAC1
27%
Migraine Pathophysiology
18%
VPAC2
18%
Vasoactivity
18%
VPAC1
18%
Gene Expression
9%
Quantitative PCR
9%
Neuropeptides
9%
Migraine Attack
9%
Migraine Treatment
9%
Myograph
9%
Migraine Prevention
9%
Phase II Trial
9%
Receptor Mechanisms
9%
Drug Target
9%
Mouse Strain
9%
Compensatory Mechanisms
9%
Migraine Drugs
9%
Wire Myography
9%
WT Control
9%
Tactile Sensitivity
9%
Von Frey Filaments
9%
Sensitivity Response
9%
Medicine and Dentistry
Migraine
100%
Carotid Artery
100%
Hypersensitivity
100%
Pituitary Adenylate Cyclase-Activating Polypeptide
100%
Artery Dilatation
100%
Vasoactive Intestinal Polypeptide Receptor 2
100%
Vasoactive Intestinal Polypeptide Receptor 1
100%
Peptide Receptor
72%
Pathophysiology
18%
Gene Expression
9%
Upregulation
9%
Real-Time Polymerase Chain Reaction
9%
Myography
9%
Neuropeptide
9%
Migraine Treatment
9%
Ex Vivo
9%
Phase II Trials
9%
Pharmacology, Toxicology and Pharmaceutical Science
Migraine
100%
Adenylate Cyclase
100%
Mouse Model
100%
Erethism
100%
Vasoactive Intestinal Polypeptide Receptor 1
100%
Vasoactive Intestinal Polypeptide Receptor 2
100%
Knockout Mouse
36%
Pathophysiology
18%
Neuropeptide
9%
Receptor
9%
Mouse
9%
Phase II Trials
9%
Neuroscience
Migraine
100%
Adenylyl Cyclase
100%
Vasoactive Intestinal Polypeptide Receptor 2
100%
Vasoactive Intestinal Polypeptide Receptor 1
100%
Neuropeptide
9%
Eicosanoid Receptor
9%
Gene Expression
9%
Real-Time Polymerase Chain Reaction
9%